Clearbridge Health's book value per share for the quarter that ended in Dec. 2023 was S$0.02.
During the past 12 months, Clearbridge Health's average Book Value Per Share Growth Rate was -76.50% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -45.50% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -24.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.
During the past 10 years, the highest 3-Year average Book Value Per Share Growth Rate of Clearbridge Health was 47.00% per year. The lowest was -45.50% per year. And the median was -4.30% per year.
Clearbridge Health's current price is S$0.012. Its book value per share for the quarter that ended in Dec. 2023 was S$0.02. Hence, today's PB Ratio of Clearbridge Health is 0.75.
During the past 10 years, the highest P/B Ratio of Clearbridge Health was 4.65. The lowest was 0.18. And the median was 1.44.
Clearbridge Health Book Value per Share Historical Data
The historical data trend for Clearbridge Health's Book Value per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Clearbridge Health's Book Value per Share
For the Diagnostics & Research subindustry, Clearbridge Health's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Clearbridge Health's PB Ratio Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Clearbridge Health's PB Ratio distribution charts can be found below:
* The bar in red indicates where Clearbridge Health's PB Ratio falls into.
Clearbridge Health Book Value per Share Calculation
Clearbridge Health's Book Value Per Share for the fiscal year that ended in Dec. 2023 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.
Clearbridge Health (SGX:1H3) Book Value per Share Explanation
Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.
For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.
Clearbridge Health Book Value per Share Related Terms
Thank you for viewing the detailed overview of Clearbridge Health's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Clearbridge Health Ltd provides health care services. It is an integrated healthcare group with end-to-end diagnostic abilities, deploying non-invasive tests to identify and manage illness. The segments of the company are Strategic investments; Healthcare systems; Medical clinics; Corporate segment and Investment. It derives key revenue from the Healthcare systems and Medical clinics. The Healthcare systems segment involves, provision of diagnostic services and manufacturing of and research and development on diagnostic related products, and provision of renal care services by partnering with medical device equipment manufacturers and hospitals. The Medical clinics segment involves, provision of general medical and clinical services. The group has a business presence in all over the world.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SGX:1H3 has been successfully added to your 